Multicentric prospettive study of validation of angiogenesis-related gene polymorphisms in hepatocellular carcinoma patients treated with sorafenib: Interim analysis of INNOVATE study.

被引:0
|
作者
Gardini, Andrea Casadei
Marisi, Giorgia
Dadduzio, Vincenzo
Faloppi, Luca
Ielasi, Luca
Vivaldi, Caterina
Rizzato, Mario Domenico
Fornaro, Lorenzo
Lonardi, Sara
Gramantieri, Laura
Pecora, Irene
Foschi, Giuseppe Francesco
Silvestris, Nicola
Fornari, Francesca
Orsi, Giulia
Rovesti, Giulia
Santini, Daniele
Zagonel, Vittorina
Cascinu, Stefano
Scartozzi, Mario
机构
[1] IRCCS, IRST, Meldola, Italy
[2] IRCCS, Ist Sci Romagnolo Studio & Cura Tumori IRST, Biosci Lab, Meldola, Italy
[3] IRCCS, Ist Oncol Veneto, Padua, Italy
[4] Univ Cagliari, Univ Hosp, Dept Med Oncol, Cagliari, Italy
[5] UNIBO, Bologna, Italy
[6] Azienda Osped Univ Pisana, Pisa, Italy
[7] IVO Veneto, Padua, Italy
[8] IRCCS, IOV, Med Oncol Unit 1, Dept Clin & Expt Oncol, Padua, Italy
[9] St Orsola Marcello Malpighi Hosp, Ctr Appl Biomed Res CRBA, Bologna, Italy
[10] Canc Inst Giovanni Paolo II, Med Oncol Unit, Bari, Italy
[11] UNIMORE, Modena, Italy
[12] Campus Biomed Univ Rome, Dept Med Oncol, Rome, Italy
[13] Univ Hosp Modena, Modena, Italy
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
4075
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Multicentric prospettive study of validation of angiogenesis-related gene polymorphisms in hepatocellular carcinoma patients treated with sorafenib: Interim analysis of INNOVATE study
    Gardini, Andrea Casadei
    Marisi, Giorgia
    Faloppi, Luca
    Dadduzio, Vincenzo
    Scarpi, Emanuela
    Ielasi, Luca
    Foschi, Francesco
    Vivaldi, Caterina
    Cardellino, Giovanni
    Tamburini, Emiliano
    Siletta, Marianna
    Negri, Francesca
    Ulivi, Paola
    Rizzato, Mario Domenico
    Gramantieri, Laura
    Conti, Fabio
    Fornaro, Lorenzo
    Porfiello, Annamaria
    Rudnas, Britt
    Santini, Daniele
    Leonetti, Alessandro
    Silvestris, Nicola
    Murgioni, Sabina
    Fornari, Francesca
    Pecora, Irene
    Argientiero, Antonella
    Lonardi, Sara
    Cascinu, Stefano
    Scartozzi, Mario
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E356 - E356
  • [2] Multicentric prospective study of validation of angiogenesis-related gene polymorphisms in HCC patients treated with sorafenib: Final results of INNOVATE study
    Casadei-Gardini, A.
    Marisi, G.
    Dadduzio, V.
    Faloppi, L.
    Ielasi, L.
    Vivaldi, C.
    Rizzato, M. D.
    Fornaro, L.
    Lonardi, S.
    Gramantieri, L.
    Pecora, I.
    Silvestris, N.
    Fornari, F.
    Orsi, G.
    Rovesti, G.
    Santini, D.
    Zagonel, V.
    Cascinu, S.
    Scartozzi, M.
    ANNALS OF ONCOLOGY, 2019, 30 : 287 - 287
  • [3] Multicentric prospective study of validation of angiogenesisrelated gene polymorphisms in hepatocellular carcinoma patients treated with sorafenib: results of INNOVATE study
    Gardia, A. Casadei
    Maris, G.
    Dadduzio, V.
    Lelasi, L.
    Vivaldi, C.
    Rizzato, M.
    Fornaro, L.
    Lonardi, S.
    Gramantieri, L.
    Pecora, I.
    Foschi, F.
    Silvestris, N.
    Fornari, F.
    Orsi, G.
    Rovesti, G.
    Santini, D.
    Zagoner, V.
    Cascinu, S.
    Scarrozzi, M.
    ANNALS OF ONCOLOGY, 2019, 30
  • [4] Multicentric prospective study of validation of angiogenesis polymorphisms in HCC patients treated with sorafenib. INNOVATE study
    Gardini, A. Casadei
    Faloppi, L.
    Daniele, B.
    Cascinu, S.
    Lonardi, S.
    Masi, G.
    Negri, F.
    Santini, D.
    Silvestris, N.
    Zagonel, V.
    Scartozzi, M.
    ANNALS OF ONCOLOGY, 2016, 27
  • [5] MULTICENTRIC PROSPECTIVE STUDY OF VALIDATION OF ANGIOGENESIS POLYMORPHISMS IN HCC PATIENTS TREATED WITH SORAFENIB. INNOVATE STUDY
    Gardini, A. C.
    Faloppi, L.
    Daniele, B.
    Foschi, G. F.
    Cascinu, S.
    Marisi, G.
    Masi, G.
    Chessa, L.
    Negri, F.
    Scarpi, E.
    Santini, D.
    Corbelli, J.
    Silvestris, N.
    Tamburini, E.
    Zagonel, V.
    Scartozzi, M.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S291 - S292
  • [6] Multicenter prospective study of angiogenesis polymorphism validation in HCC patients treated with sorafenib. An INNOVATE study protocol
    Gardini, Andrea Casadei
    Faloppi, Luca
    Aprile, Giuseppe
    Brunetti, Oronzo
    Caparello, Chiara
    Corbelli, Jody
    Chessa, Luchino
    Bruno, Daniele
    Ercolani, Giorgio
    Leonetti, Alessandro
    de Stefano, Giorgio
    Farella, Nunzia
    Foschi, Francesco Giuseppe
    Lanzi, Arianna
    Dadduzio, Vincenzo
    Marisi, Giorgia
    Masi, Gianluca
    Negri, Francesca, V
    Pagan, Flavia
    Santini, Daniele
    Scarpi, Emanuela
    Silletta, Marianna
    Silvestris, Nicola
    Tamburini, Emiliano
    Tassinari, Davide
    Vivaldi, Caterina
    Gentilucci, Umberto Vespasiani
    Zagonel, Vittorina
    Calvetti, Lorenzo
    Cascinu, Stefano
    Frassineti, Giovanni Luca
    Scartozzi, Mario
    TUMORI JOURNAL, 2018, 104 (06): : 476 - 479
  • [7] A study on angiogenesis-related matrix metalloproteinase networks in primary hepatocellular carcinoma
    Ishii, Y
    Nakasato, Y
    Kobayashi, S
    Yamazaki, Y
    Aoki, T
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2003, 22 (03) : 461 - 470
  • [8] Unresectable hepatocellular carcinoma treated with lenvatinib or sorafenib: A disease modeling study.
    Tremblay, Gabriel
    Copher, Ronda
    Garib, Shan Ashton
    Pan, Janice
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [9] First interim results from a non-interventional study in hepatocellular carcinoma patients treated with sorafenib - the INSIGHT study
    Ganten, T. M.
    Schott, E.
    Goehler, T.
    Wiest, R.
    Malfertheiner, P.
    Stauber, R.
    Buder, R.
    Achilles, K.
    Gerken, G.
    ONKOLOGIE, 2011, 34 : 215 - 215
  • [10] Association of NOS3 and ANGPT2 Gene Polymorphisms with Survival in Patients with Hepatocellular Carcinoma Receiving Sorafenib: Results of the Multicenter Prospective INNOVATE Study
    Casadei-Gardini, Andrea
    Marisi, Giorgia
    Dadduzio, Vincenzo
    Gramantieri, Laura
    Faloppi, Luca
    Ulivi, Paola
    Foschi, Francesco Giuseppe
    Tamburini, Emiliano
    Vivaldi, Caterina
    Rizzato, Mario Domenico
    Ielasi, Luca
    Canale, Matteo
    Conti, Fabio
    Rudnas, Britt
    Fornaro, Lorenzo
    Silvestris, Nicola
    Silletta, Marianna
    Cardellino, Giovanni Gerardo
    Lonardi, Sara
    Fornari, Francesca
    Orsi, Giulia
    Rovesti, Giulia
    Zagonel, Vittorina
    Cascinu, Stefano
    Scartozzi, Mario
    CLINICAL CANCER RESEARCH, 2020, 26 (17) : 4485 - 4493